Bladder Cancer Trial, Recruiting NCT06992986 Sponsor: Regina Elena Cancer Institute Condition: Bladder Cancer
Back to Bladder Cancer

Bladder Cancer Trial, Recruiting

NCT06992986
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

If you have bladder cancer:

  • You have been diagnosed with bladder cancer
  • Your urine test shows no signs of infection (negative urine culture)
  • Your cancer has been confirmed by tissue testing as a specific type called urothelial carcinoma
  • You are scheduled to have your bladder surgically removed (radical cystectomy)

If you are a healthy volunteer or have no known illness:

  • You are a man within a certain age range (confirm specific age range with trial site)
  • You may be recruited through an occupational health or workplace medicine department at the institution running the trial

If you have a non-cancerous urinary condition:

  • You have a benign (non-cancerous) urinary condition such as kidney cysts, an enlarged prostate causing blockage, or a blockage in the tube connecting the kidney to the bladder
  • You are scheduled to have surgery for one of these conditions

Who may not be able to join:

If you have bladder cancer:

  • You have or have had another type of cancer
  • You have previously had a treatment called BCG therapy (a type of bladder treatment)
  • You use a permanent urinary catheter
  • You have taken antibiotics within the two months before joining the trial
  • You have a history of sexually transmitted diseases
  • You have a long-term inflammatory bowel condition
  • You have previously received chemotherapy or other treatment before surgery (neoadjuvant therapy)

If you are a healthy volunteer:

  • You have diabetes
  • You have chronic kidney disease
  • You have a heart condition
  • You have a liver condition

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Giuseppe Simone, Doctor, IRCCS National Cancer Institute

Phone: +39-06-5266.5005

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Regina Elena Cancer Institute
Registry
ClinicalTrials.gov
Start date
6 February 2024
Est. completion
6 July 2025

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Differences in the bladder microbiome

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov